Vivonics is a private, R&D-focused medical technology firm leveraging a multidisciplinary engineering team and a strong network of clinical and military collaborators to develop advanced health monitoring and intervention systems. The company has a clear dual-track focus, securing significant non-dilutive funding from U.S. Department of Defense agencies and the NIH for military performance and casualty care applications, while also pursuing commercial clinical pathways in areas like vestibular stimulation and diabetic care. Its business model appears centered on government R&D contracts and grants to de-risk technology development, with the aim of ultimately commercializing products for broader healthcare markets.
Integrated suite of engineering capabilities for mobile physiological monitoring, transdermal neurological stimulation, and clinical decision support, leveraging miniaturized wearable tech, contactless sensing, and non-invasive intervention methods.
Funding History
2
Total raised:$6.5M
Seed$4MUndisclosed
Grant$2.5MNational Institutes of Health
Opportunities
Significant opportunity to leverage non-dilutive U.S.
government funding to de-risk advanced technologies for military use, then spin out lower-cost, FDA-cleared versions for large commercial markets in wearable monitoring, diabetic care, and neuromodulation.
The growing emphasis on soldier performance and remote health monitoring creates a tailwind for its core competencies.
Risk Factors
High dependency on cyclical and competitive government grant funding poses a continuous liquidity risk.
The transition from successful prototype development under contract to scalable, commercially viable medical products involves significant technical, regulatory, and market execution risks in crowded fields.
Competitive Landscape
Operates in competitive spaces including wearable biosensors (e.g., Philips, Garmin, startups), neuromodulation devices (e.g., NeuroMetrix, Hinge Health), and specialized military contractors. Differentiation relies on deep integration of multiple modalities (monitoring + stimulation) and unique access to military end-users for development and validation.
